# Efgartigimod for Stiff Person Syndrome (ESPS)

> **NCT06528392** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of South Florida** · enrollment: 10 (estimated)

## Conditions studied

- Stiff-Person Syndrome

## Interventions

- **BIOLOGICAL:** Efgartigimod

## Key facts

- **NCT ID:** NCT06528392
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06528392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06528392, "Efgartigimod for Stiff Person Syndrome (ESPS)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06528392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*